Korea Bio-Gen Co.Ltd (318000) — Net Asset Momentum
Korea Bio-Gen Co.Ltd (318000) recorded a net asset momentum of 6.8% as of December 2024, with net assets of ₩44.91 Billion KRW. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Korea Bio-Gen Co.Ltd (318000) liquidity interval to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Korea Bio-Gen Co.Ltd Net Asset Momentum (2017–2024)
This chart tracks Korea Bio-Gen Co.Ltd's year-over-year net asset growth across 8 annual reporting periods from 2017 to 2024. The most recent momentum reading is +6.8%, with net assets of ₩44.91 Billion KRW as of December 2024. Read debt load of Korea Bio-Gen Co.Ltd for a breakdown of total debt and financial obligations.
Annual Net Asset History for Korea Bio-Gen Co.Ltd (2017–2024)
The table below shows the complete annual net asset history for Korea Bio-Gen Co.Ltd from 2017 to 2024, covering 8 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Korea Bio-Gen Co.Ltd market cap and net worth.
| Year | Net Assets (KRW) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | ₩44.91 Billion | ₩51.64 Billion | ₩6.73 Billion | ▲ +6.8% |
| 2023 | ₩42.05 Billion | ₩45.95 Billion | ₩3.90 Billion | ▲ +20.3% |
| 2022 | ₩34.95 Billion | ₩43.07 Billion | ₩8.13 Billion | ▲ +10.6% |
| 2021 | ₩31.61 Billion | ₩42.00 Billion | ₩10.39 Billion | ▲ +12.2% |
| 2020 | ₩28.16 Billion | ₩31.07 Billion | ₩2.91 Billion | ▲ +9.6% |
| 2019 | ₩25.69 Billion | ₩28.16 Billion | ₩2.47 Billion | ▲ +134.1% |
| 2018 | ₩10.97 Billion | ₩19.80 Billion | ₩8.83 Billion | ▲ +22.9% |
| 2017 | ₩8.93 Billion | ₩16.80 Billion | ₩7.88 Billion | — |